GS0051: Synthetic injectable or implantable, biodegradable biomaterials consisting of microparticles, nanoparticles, hydrogels, scaffolds, or implants that comprise poly-DL-lactide-co-glycolides, polylactides, polyglycolides, polyethylene glycols, or copolymers thereof and incorporate small molecule therapeutics, peptides, proteins, oligonucleotides, or cells for the treatment of neurological conditions, including, acute and chronic pain, post-operative pain, neuropathic pain, spinal cord injury, neurotrauma, neuro-inflammation, neurodegenerative diseases, seizure disorders, neurological autoimmune disorders, and neuro-oncological diseases in the field of neuroscience
GS0421: Scientific research and research consulting services in the field of neuroscience
Case File Event Statements
2/3/2023 - a year ago
36 - CANCELLED SEC. 8 (6-YR)Type:C8..
7/19/2021 - 3 years ago
35 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1